Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Giant cell and Takayasu's arteritis.

B A Bengtsson1, R Andersson

  • 1University of Göteborg, Sweden.

Current Opinion in Rheumatology
|February 1, 1991
PubMed
Summary

Giant cell arteritis (GCA) is a vasculitis primarily affecting older women, with increasing incidence. While glucocorticosteroids are the standard treatment, monitoring disease activity with erythrocyte sedimentation rate is crucial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hormones, body composition and cardiovascular risk.

Asia Pacific journal of clinical nutrition·2014
Same author

The effects of growth hormone on body composition.

Asia Pacific journal of clinical nutrition·2014
Same author

Detection of growth hormone abuse in sport.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society·2007
Same author

Effects of GH and insulin-like growth factor-I on body composition.

Journal of endocrinological investigation·2004
Same author

Increased Interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness.

Clinical endocrinology·2003
Same author

Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.

Clinical endocrinology·2002

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis predominantly affecting the elderly.
  • The incidence of GCA is rising, particularly in women.
  • The exact etiology remains unknown, but a cellular immune response to arterial wall antigens is suspected.

Purpose of the Study:

  • To review the epidemiology, clinical presentation, and management of giant cell arteritis.
  • To highlight the importance of constitutional symptoms and large artery involvement.
  • To discuss current treatment strategies and monitoring methods for GCA.

Main Methods:

  • Literature review of giant cell arteritis.
  • Analysis of epidemiological trends and clinical manifestations.
  • Evaluation of treatment outcomes and monitoring parameters.

Main Results:

  • GCA incidence is increasing, especially in women.
  • Constitutional symptoms are more prevalent than previously thought.
  • Large artery involvement can occur independently of classic GCA symptoms.
  • Peripheral synovitis is uncommon and transient in polymyalgia rheumatica.
  • Glucocorticosteroids are the mainstay of GCA treatment.
  • Low-dose maintenance corticosteroids minimize osteoporosis risk.
  • Erythrocyte sedimentation rate is the preferred method for monitoring GCA activity.

Conclusions:

  • Giant cell arteritis requires comprehensive management focusing on early diagnosis and appropriate treatment.
  • Effective monitoring using erythrocyte sedimentation rate aids in long-term patient care.
  • Further research into the etiology of GCA is warranted.

Related Experiment Videos